{"description":"Only All-Cause Mortality, Serious Adverse Events, and Adverse Events of Special Interest (AESI) were collected for this study. All-cause mortality and Serious Adverse Events were collected for both arms as defined in the clinicaltrials.gov definition. AESIs were collected only for subjects on the intervention arm, including bleeding, bruising, skin infection, edema, dry skin, urticaria, pruritus, rash, pain or flushing at the acupuncture site, dizziness, syncope, fatigue, or hyperhidrosis.","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":8,"description":"Acupuncture: 12 acupuncture sessions over 10 weeks","id":"EG000","otherNumAffected":0,"otherNumAtRisk":8,"seriousNumAffected":0,"seriousNumAtRisk":8,"title":"Acupuncture"},{"deathsNumAffected":0,"deathsNumAtRisk":4,"description":"Standard of Care CIPN management: Investigator directed standard of care management of CIPN","id":"EG001","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":4,"title":"Standard of Care"}],"frequencyThreshold":"0","timeFrame":"AESIs were collected for approximately 10 weeks for the duration of the acupuncture treatment (for those on the intervention arm) and collected through 30 days after last acupuncture session. Serious adverse events and all-cause mortality were monitored and collected for both arms throughout the study, approximately 10 weeks."}